These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage. Le Roux P; Pollack CV; Milan M; Schaefer A J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496 [TBL] [Abstract][Full Text] [Related]
5. Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants. Purrucker JC; Haas K; Rizos T; Khan S; Wolf M; Hennerici MG; Poli S; Kleinschnitz C; Steiner T; Heuschmann PU; Veltkamp R JAMA Neurol; 2016 Feb; 73(2):169-77. PubMed ID: 26660118 [TBL] [Abstract][Full Text] [Related]
6. Intracerebral bleeding in patients on antithrombotic agents. Veltkamp R; Rizos T; Horstmann S Semin Thromb Hemost; 2013 Nov; 39(8):963-71. PubMed ID: 24114010 [TBL] [Abstract][Full Text] [Related]
7. In Models of Intracerebral Hemorrhage, Rivaroxaban is Superior to Warfarin to Limit Blood Brain Barrier Disruption and Hematoma Expansion. Sawada S; Ono Y; Egashira Y; Takagi T; Tsuruma K; Shimazawa M; Iwama T; Hara H Curr Neurovasc Res; 2017; 14(2):96-103. PubMed ID: 27993122 [TBL] [Abstract][Full Text] [Related]
8. Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro. Perzborn E; Heitmeier S; Laux V; Buchmüller A Thromb Res; 2014 Apr; 133(4):671-81. PubMed ID: 24529498 [TBL] [Abstract][Full Text] [Related]
9. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Aguilar MI; Hart RG; Kase CS; Freeman WD; Hoeben BJ; García RC; Ansell JE; Mayer SA; Norrving B; Rosand J; Steiner T; Wijdicks EF; Yamaguchi T; Yasaka M Mayo Clin Proc; 2007 Jan; 82(1):82-92. PubMed ID: 17285789 [TBL] [Abstract][Full Text] [Related]
10. Favorable outcome of rivaroxaban-associated intracerebral hemorrhage reversed by 4-factor prothrombin complex concentrate: impact on thrombin generation. Kauffmann S; Chabanne R; Coste A; Longeras F; Sinegre T; Schmidt J; Samama CM; Constantin JM; Lebreton A A A Case Rep; 2015 Jun; 4(11):151-4. PubMed ID: 26035221 [TBL] [Abstract][Full Text] [Related]
11. Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage. Sarode R; Matevosyan K; Bhagat R; Rutherford C; Madden C; Beshay JE J Neurosurg; 2012 Mar; 116(3):491-7. PubMed ID: 22175718 [TBL] [Abstract][Full Text] [Related]
12. Secondary hematoma expansion in intracerebral hemorrhage during rivaroxaban therapy. Purrucker JC; Capper D; Behrens L; Veltkamp R Am J Emerg Med; 2014 Aug; 32(8):947.e3-5. PubMed ID: 24602898 [No Abstract] [Full Text] [Related]
13. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Huttner HB; Schellinger PD; Hartmann M; Köhrmann M; Juettler E; Wikner J; Mueller S; Meyding-Lamade U; Strobl R; Mansmann U; Schwab S; Steiner T Stroke; 2006 Jun; 37(6):1465-70. PubMed ID: 16675739 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of intracerebral hemorrhage during rivaroxaban treatment: comparison with those during warfarin. Hagii J; Tomita H; Metoki N; Saito S; Shiroto H; Hitomi H; Kamada T; Seino S; Takahashi K; Baba Y; Sasaki S; Uchizawa T; Iwata M; Matsumoto S; Osanai T; Yasujima M; Okumura K Stroke; 2014 Sep; 45(9):2805-7. PubMed ID: 25082810 [TBL] [Abstract][Full Text] [Related]
15. CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage. Navarro-Oviedo M; Marta-Enguita J; Roncal C; Rodríguez JA; Zandio B; Lecumberri R; Hermida J; Oyarzabal J; Pineda-Lucena A; Páramo JA; Muñoz R; Orbe J Thromb Haemost; 2022 Aug; 122(8):1314-1325. PubMed ID: 35114692 [TBL] [Abstract][Full Text] [Related]
16. Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage. Schlunk F; Van Cott EM; Hayakawa K; Pfeilschifter W; Lo EH; Foerch C Stroke; 2012 Jan; 43(1):246-9. PubMed ID: 21998055 [TBL] [Abstract][Full Text] [Related]
17. Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography. Won SY; Schlunk F; Dinkel J; Karatas H; Leung W; Hayakawa K; Lauer A; Steinmetz H; Lo EH; Foerch C; Gupta R Stroke; 2013 Oct; 44(10):2883-90. PubMed ID: 23920016 [TBL] [Abstract][Full Text] [Related]
19. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013. Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P; Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130 [TBL] [Abstract][Full Text] [Related]
20. Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator. Pfeilschifter W; Kashefiolasl S; Lauer A; Steinmetz H; Foerch C Neuroscience; 2013 Oct; 250():181-8. PubMed ID: 23856067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]